Sheldon Sloan

Insider Reports History

Location
221 Crescent Street, Suite 105, Waltham, MA
Signature
/s/ Heidy King-Jones, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Sheldon Sloan:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Spyre Therapeutics, Inc. Chief Medical Officer Stock Option (Right to Buy) 95.5K Jan 15, 2025 Direct

Insider Reports Filed by Sheldon Sloan

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SYRE Spyre Therapeutics, Inc. Jan 15, 2025 1 $0 4 Jan 17, 2025 Chief Medical Officer
SYRE Spyre Therapeutics, Inc. Oct 1, 2024 1 $0 4 Oct 1, 2024 Chief Medical Officer
SYRE Spyre Therapeutics, Inc. Oct 1, 2024 0 $0 3 Oct 1, 2024 Chief Medical Officer